 | LY803 | Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores-LY803 | each | Sign In for Pricing | |
 | BNC473350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC403348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF640R conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNUM3348-50 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
 | BNCB3348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC043348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF405S conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB2836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNCB3348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC742576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC742836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF740 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC472836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNUB2576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC743348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF740 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| OV208a | High density ovary cancer and ovary tissue array (1999 WHO classification), with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores, replacing OV208 | 69 Cases / 207 Cores | Sign In for Pricing | |
| RA0840-C.5 | Recombinant NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) ; Clone rNKX3.1/6620 | 0.5 mL | Sign In for Pricing | |
| RA0840-C1 | Recombinant NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) ; Clone rNKX3.1/6620 | 1 mL | Sign In for Pricing | |
| BC05002c | Colon spectrum tissue array, including adenocarcinoma，metastatic carcinoma, adenoma, Crohn's disease, tuberculosis, chronic colitis, NAT and normal colon tissue, pathology grade, TNM and clinicla stage , 78 cases/80 cores（core size 1.5mm）, replacing BC05002b | 1 Each | Sign In for Pricing | |
 | OV802c | Ovarian cancer and metastatic adenocarcinoma tissue array with normal adjacent ovarian tissue, including pathology grade, TNM and clinical stage (AJCC 8th edition), p53 IHC, 80 cases/80 cores (core size 1.5mm) . | 1 Each | Sign In for Pricing | |
 | BNUB3350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC882576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNUM3350-50 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
 | BNC403350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF640R conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC682836-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF568 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC882836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC883350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF488A conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| VAng-Wyb8646-inquire | Cancer Antigen CEA Antigen (Human Metastatic Liver of Colon Adenocarcinoma) | Inquire | Sign In for Pricing | |
| OV8010b | Mid-advanced stage ovary cancer tissue array with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV8010 | 80 Cases / 80 Cores | Sign In for Pricing | |
| MBS4381116-01 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.02 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4381116-02 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4381116-03 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |
| MBS4381116-04 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 5x 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4381116-05 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 5x 0.1 mg (Without BSA & Azide at 1mg/mL) | Sign In for Pricing | |
| 36-2860-100 | Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Monoclonal Antibody (Clone: NKX3.1/3347) | 100 µg | Sign In for Pricing | |
| 36-2861-20 | Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Monoclonal Antibody (Clone: NKX3.1/3348) | 20 µg | Sign In for Pricing | |
 | BNC743347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC683347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF568 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC042576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF405S conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC402836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF640R conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNUB2576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC403347-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF640R conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC403347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF640R conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC402576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF640R conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUB3347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC472576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC682576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF568 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC743347-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF740 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| 36-2858-20 | Anti-NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) Monoclonal Antibody (Clone: NKX3.1/3350) | 20 µg | Sign In for Pricing | |
| CO953a | Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953 | 1 Each | Sign In for Pricing | |
| VA1001a | Appendix spectrum of diseases with appendix tissue array, including carcinoid, adenocarcinoma, metastatic carcinoid, tubular adenoma, acute appendicitis, chronic appendicitis, pathology grade, TNM and clinical stage (AJCC 8.0), 50 cases/100 cores (1.5mm) | 1 Each | Sign In for Pricing | |